If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Publisher: Elsevier

Related content
Volume 71, Number 6, December 1996

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Quality assurance after process changes of the production of a therapeutic antibody
pp. 395-403(9)
Authors: Brass, J.M.; Krummen, K.; Moll-Kaufmann, C.

Favourites:Add to Favourites

Quality assurance for biopharmaceuticals: An overview of regulations, methods and problems
pp. 421-438(18)
Authors: Muller, K.M.; Gempeler, M.R.; Scheiwe, M.; Zeugin, B.T.

Favourites:Add to Favourites

Requirements for the quality control of chemically synthesized peptides and biotechnologically produced proteins
pp. 439-446(8)
Authors: Bichsel, V.E.; Curcio, V.; Gassmann, R.; Otto, H.

Favourites:Add to Favourites

Special considerations concerning regulatory requirements and drug development for peptides and biotech products in the EU
pp. 447-458(12)
Authors: Braun, A.; Gassmann, R.; Kraus, K.; Lorenzi, G.; Weigel, U.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more